The scope of the present review is to discuss the prognosis of diabetic renal disease, putative progression promoters and the possibilities for treatment and prediction of treatment efficacy. The recent changes in the incidence of diabetic nephropathy in Type 1 diabetes mellitus are discussed. Promo
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule
โ Scribed by Y. Vergouwe; S. S. Soedamah-Muthu; J. Zgibor; N. Chaturvedi; C. Forsblom; J. K. Snell-Bergeon; D. M. Maahs; P.-H. Groop; M. Rewers; T. J. Orchard; J. H. Fuller; K. G. M. Moons
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 171 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
To describe the course and risk factors for development and progression of retinopathy, we studied a cohort of 333 Israeli Jewish patients with Type 1 (insulin-dependent) diabetes mellitus. The median age at diagnosis was 9.5 (range 0.04-26.2) years and the median duration of follow-up was 14 (range
The prodromal phase of type 1 diabetes is characterised by the appearance of multiple islet-cell related autoantibodies (Aab). The major target antigens are islet-cell antigen, glutamic acid decarboxylase (GAD), protein-tyrosine phosphatase-2 (IA-2) and insulin. Insulin autoantibodies (IAA), in cont